[ad_1] GlaxoSmithKline's experimental drug GSK095 is designed to work with checkpoint inhibitor drugs in the hope of giving the immune system the power to launch a more aggressive attack against tumors than …
Read More »GSK pancreatic cancer drug goes to phase 1 of Merck's Keytruda combo after a positive test in mice
